Sanofi Quarterly Results for Trading Insights
SANOFI • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹120 Cr
QMar 2025
Sanofi Quarterly Results Key Highlights
- Revenue of ₹539 Cr in Mar 2025 (+2.5% vs Sept 2024, -6.9% vs Mar 2024)
- Net Profit of ₹120 Cr in Mar 2025 (+46.3% vs Sept 2024, -12.4% vs Mar 2024)
- EBITDA of ₹175 Cr in Mar 2025 (+43.4% vs Sept 2024)
- Operating Margin of 32.0% in Mar 2025 (+9.0pp vs Sept 2024)
- Earnings Per Share of ₹51.89 in Mar 2025 (+45.4% vs Sept 2024)
Sanofi Quarterly Results Analysis
| Metric | Mar 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 539 | 526 | 579 | 503 | 529 | 2.5% | -6.9% |
| Net Profit (₹ Cr) | 120 | 82 | 137 | 103 | 91 | - | - |
| EBITDA (₹ Cr) | 175 | 122 | 179 | 137 | 132 | - | - |
| EPS (₹) | 51.89 | 35.69 | 59.31 | 44.81 | 39.64 | - | - |
| Operating Margin (%) | 32.0% | 23.0% | 22.0% | 21.0% | 23.0% | - | - |
Sanofi Share Price Trend Around Quarterly Results
Visualize Sanofi's 1-year price movement across quarterly results — ideal for logging trades in Sanofi share price
chart using Tickjournal. All values in ₹.
Related Pages for Sanofi
Additional stock information and data for SANOFI
Revenue Trend (₹ Cr)
Jun 2024
503
Mar 2024
579
Sept 2024
526
Mar 2025
539
Net Profit Trend (₹ Cr)
Jun 2024
103
Mar 2024
137
Sept 2024
82
Mar 2025
120
Operating Margin Trend (%)
Jun 2024
21.0%
Mar 2024
22.0%
Sept 2024
23.0%
Mar 2025
32.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Sanofi quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores